These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37295177)

  • 1. An Individual Patient-Level Meta-Analysis of Ischemic Versus Nonischemic Cardiomyopathy and Trajectory of Decongestion in Patients With Acute Decompensated Heart Failure.
    Akhtar KH; Maqsood MH; Ansari SA; Siddiqi TJ; Arshad MS; Greene SJ; Butler J; Khan MS
    Am J Cardiol; 2023 Aug; 200():32-39. PubMed ID: 37295177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right ventricular free wall strain in acutely decompensated heart failure patients with ischemic and non-ischemic cardiomyopathy.
    Miric D; Barac A; Capkun V; Bakovic D
    Echocardiography; 2021 Oct; 38(10):1747-1753. PubMed ID: 34555211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure.
    Lee WC; Wu PJ; Fang HY; Fang YN; Chen HC; Tong MS; Sung PH; Lee CH; Chung WJ
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
    Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
    JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure.
    Patel RB; Vaduganathan M; Rikhi A; Chakraborty H; Greene SJ; Hernandez AF; Felker GM; Redfield MM; Butler J; Shah SJ
    JACC Heart Fail; 2019 Jan; 7(1):47-55. PubMed ID: 30409707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
    Kociol RD; McNulty SE; Hernandez AF; Lee KL; Redfield MM; Tracy RP; Braunwald E; O'Connor CM; Felker GM;
    Circ Heart Fail; 2013 Mar; 6(2):240-5. PubMed ID: 23250981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.
    Wever-Pinzon J; Selzman CH; Stoddard G; Wever-Pinzon O; Catino A; Kfoury AG; Diakos NA; Reid BB; McKellar S; Bonios M; Koliopoulou A; Budge D; Kelkhoff A; Stehlik J; Fang JC; Drakos SG
    J Am Coll Cardiol; 2016 Oct; 68(16):1741-1752. PubMed ID: 27737740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonischemic or Dual Cardiomyopathy in Patients With Coronary Artery Disease.
    Bawaskar P; Thomas N; Ismail K; Guo Y; Chhikara S; Athwal PSS; Ranum A; Jadhav A; Hooker Mendez A; Nadkarni I; Frerichs D; Velangi P; Ergando T; Akram H; Kanda A; Shenoy C
    Circulation; 2024 Mar; 149(11):807-821. PubMed ID: 37929565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the Clinical Outcome of Ischemic and Nonischemic Cardiomyopathy in Heart Failure With Concomitant Opioid Use Disorder.
    Gharbin J; Winful A; Hassan MA; Bajaj S; Batta Y; Alebna P; Rhodd S; Taha M; Fatima U; Mehrotra P
    Curr Probl Cardiol; 2023 May; 48(5):101609. PubMed ID: 36690309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial.
    Lee TC; Qian M; Mu L; Di Tullio MR; Graham S; Mann DL; Nakanishi K; Teerlink JR; Lip GYH; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Ye S;
    ESC Heart Fail; 2019 Apr; 6(2):297-307. PubMed ID: 30816013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.
    Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial segmental thickness variability on echocardiography is a highly sensitive and specific marker to distinguish ischemic and non-ischemic dilated cardiomyopathy in new onset heart failure.
    Katikireddy CK; Acharya T
    Int J Cardiovasc Imaging; 2019 May; 35(5):791-798. PubMed ID: 30594979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter Ablation for Ventricular Tachycardia in Ischaemic Versus Non-Ischaemic Cardiomyopathy: A Systematic Review and Meta-Analysis.
    Kanagaratnam A; Virk SA; Pham T; Anderson RD; Turnbull S; Campbell T; Bennett R; Thomas SP; Lee G; Kumar S
    Heart Lung Circ; 2022 Aug; 31(8):1064-1074. PubMed ID: 35643798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trajectory of Decongestion and Mortality in Young Adults with Acute Heart Failure.
    Jain V; Maqsood MH; Siddiqi TJ; Siddiqi AK; Baloch ZQ; Kittleson MM; Fudim M; Felker GM; Greene SJ; Butler J; Khan MS
    Curr Probl Cardiol; 2023 Apr; 48(4):101579. PubMed ID: 36592843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of ventricular tachyarrhythmias and their susceptibility to antitachycardia pacing termination in patients with ischemic and nonischemic cardiomyopathy: A patient-level meta-analysis of three large clinical trials.
    Cheng A; Joung B; Brown ML; Koehler J; Lexcen DR; Sanders P; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2720-2726. PubMed ID: 32700390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
    Briongos-Figuero S; Estévez A; Luisa Pérez M; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Basterra N; Rodríguez A; Lozano I; Muñoz-Aguilera R
    Int J Cardiol; 2019 Jan; 274():163-169. PubMed ID: 30206014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease.
    Kumar S; Romero J; Mehta NK; Fujii A; Kapur S; Baldinger SH; Barbhaiya CR; Koplan BA; John RM; Epstein LM; Michaud GF; Tedrow UB; Stevenson WG
    Heart Rhythm; 2016 Oct; 13(10):1957-63. PubMed ID: 27392945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative deformation analysis differentiates ischaemic and non-ischaemic cardiomyopathy: sub-group analysis of the VINDICATE trial.
    Foley JRJ; Swoboda PP; Fent GJ; Garg P; McDiarmid AK; Ripley DP; Erhayiem B; Musa TA; Dobson LE; Plein S; Witte KK; Greenwood JP
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):816-823. PubMed ID: 29029139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.